New: the shifts that come back across the latest research. See what to focus on

Horizon: now

Drug launches now require better teamwork to succeed

Drug launch teams must coordinate outreach and use repeatable processes because launch volumes are rising while commercial windows shrink.

In the report's words: “Drug launches now require coordinated engagement across more decision-makers and repeatable processes as launch volumes rise and commercial windows shrink.”p3–6

The number that matters

55%p4

increase in global novel drug launches

Where to focus

  1. 1Engage treatment decision-makers across hospitals, payers, patients, and cliniciansp5–6
  2. 2Use repeatable processes to execute more drug launches quicklyp6
  3. 3Connect data so commercial and medical teams coordinate outreachp8, p10

The details

Who it affects

Commercial launch leaders at life sciences companies; company size unspecified.p9–10

What holds them back

  • Launch teams struggle to reach treatment decision-makers because prescribing depends on hospitals, payers, patients, and clinicians with different priorities.p5–6
  • Launch teams struggle to execute more launches quickly because manual work and starting from scratch do not scale.p6
  • Commercial and medical teams struggle to coordinate outreach because disconnected data and execution create duplicated effort.p8, p10

The numbers

  • 394 novel active substances launched globally in 2020–2024, up 55% from 2015–2019, increasing launch workload.p4
  • 77.6% of U.S. HCPs were employed by hospitals, health systems, or corporations in January 2024, broadening the influences on prescribing.p3

What people search for

  • pharma launch checklist
  • drug launch plan template
  • how to find drug prescribing decision makers
  • CRM for pharma launch teams
  • coordinate pharma sales and medical teams
  • track drug launch campaign performance